Charles River Laboratories International, Inc. Common Stock (NY:CRL)

374.94 +0.96 (+0.26%)

Delayed Quote Updated: 2:38 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

23 24 Next >

Charles River Laboratories Announces Third-Quarter 2024 Results

November 06, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

P/E Ratio Insights for Charles River ↗

October 25, 2024

Via Benzinga

This Ferguson Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

October 23, 2024

Via Benzinga

Charles River Launches New Retrogenix® Non-Human Protein Library

October 17, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Evaluating Charles River: Insights From 12 Financial Analysts ↗

October 07, 2024

Via Benzinga

The Analyst Verdict: Charles River In The Eyes Of 10 Experts ↗

September 20, 2024

Via Benzinga

Critical Insights From Charles River Analyst Ratings: What You Need To Know ↗

August 08, 2024

Via Benzinga

Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call

October 16, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

This Alibaba Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

October 07, 2024

Via Benzinga

This Netflix Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday ↗

October 07, 2024

Via Benzinga

Charles River Provides Translational Expertise at Neuroscience 2024

October 03, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease

October 02, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research

September 17, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio? ↗

September 08, 2024

10 worst performing large-cap stocks in August: Super Micro, Dollar General, Snap, PDD Holdings, Intel, Tencent Music, Gold Fields, Charles River, Moderna, Neurocrine Biosciences.

Via Benzinga

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience

September 04, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

September 03, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers ↗

August 31, 2024

The equity market was volatile in August, with the weakness seen early in the month dissipating amid a rise in rate-cut bets.

Via Benzinga

Topics Stocks

CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

August 13, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Warner Bros, Airbnb And Monster Beverage Are Among Top 10 Large Cap Losers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio? ↗

August 11, 2024

These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. being the worst performers.

Via Benzinga

EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase Trials Underway ↗

August 08, 2024

Oragenics announced its lead candidate, ONP-002, for treating concussion, which shows no cardiotoxicity in studies. Designed for nasal delivery to the brain, ONP-002 aims to address the significant...

Via Benzinga

Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday ↗

August 08, 2024

Via Benzinga

Wall Street Ends Wednesday In The Red As Risk Sentiment Remains Fragile: S&P 500 Movers At The Close ↗

August 07, 2024

U.S. markets close lower on Wednesday after bounce back on Tuesday, with small caps hit hardest. Investors assess economic outlook and Fed rate cut.

Via Benzinga

Topics Economy Stocks

Charles River Laboratories Stock Sinks As It Warns Of Continued Biotech Demand Slump, Lowers Forecast ↗

August 07, 2024

Charles River Laboratories reported Q2 2024 revenue of $1.03 billion, a 3.2% decrease year-over-year, surpassing the $1.024 billion consensus. Adjusted EPS rose to $2.80 from $2.69. The company revised...

Via Benzinga

Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024 ↗

August 07, 2024

Pharmaceutical demand hit the skids in the second quarter and isn't expected to improve this year.

Via Investor's Business Daily

Charles River Laboratories Announces Second-Quarter 2024 Results

August 07, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development

July 30, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery

July 24, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call

July 16, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

Apple To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

July 10, 2024

Via Benzinga

Charles River to Perform Plasmid Manufacturing for AAVantgarde

July 08, 2024

From Charles River Laboratories International, Inc.

Via Business Wire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.